LPCN logo

Lipocine (LPCN) Working Capital

Annual Working Capital

$20.23 M
-$12.23 M-37.67%

December 31, 2023


Summary


Performance

LPCN Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLPCNbalance sheetmetrics:

Quarterly Working Capital

$18.92 M
-$2.16 M-10.26%

September 30, 2024


Summary


Performance

LPCN Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLPCNbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

LPCN Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-37.7%-6.5%
3 y3 years+7.9%-25.1%
5 y5 years+24.0%-25.1%

LPCN Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-50.4%at low-53.6%at low
5 y5-year-50.4%+37.9%-53.6%+29.0%
alltimeall time-54.8%>+9999.0%-57.7%>+9999.0%

Lipocine Working Capital History

DateAnnualQuarterly
Sep 2024
-
$18.92 M(-10.3%)
Jun 2024
-
$21.09 M(-11.5%)
Mar 2024
-
$23.83 M(+17.8%)
Dec 2023
$20.23 M(-37.7%)
$20.23 M(-9.6%)
Sep 2023
-
$22.37 M(-11.4%)
Jun 2023
-
$25.26 M(-11.9%)
Mar 2023
-
$28.68 M(-11.6%)
Dec 2022
$32.46 M(-20.4%)
$32.46 M(-6.2%)
Sep 2022
-
$34.60 M(-4.9%)
Jun 2022
-
$36.37 M(-9.0%)
Mar 2022
-
$39.98 M(-1.9%)
Dec 2021
$40.76 M(+117.5%)
$40.76 M(+20.1%)
Sep 2021
-
$33.93 M(-11.5%)
Jun 2021
-
$38.35 M(-5.4%)
Mar 2021
-
$40.55 M(+116.3%)
Dec 2020
$18.75 M(+27.8%)
$18.75 M(-1.0%)
Sep 2020
-
$18.94 M(-1.5%)
Jun 2020
-
$19.23 M(+13.7%)
Mar 2020
-
$16.91 M(+15.3%)
Dec 2019
$14.67 M(-10.1%)
$14.67 M(+21.4%)
Sep 2019
-
$12.08 M(-20.5%)
Jun 2019
-
$15.20 M(-18.6%)
Mar 2019
-
$18.67 M(+14.4%)
Dec 2018
$16.32 M
$16.32 M(-16.6%)
Sep 2018
-
$19.57 M(-12.7%)
Jun 2018
-
$22.41 M(-11.6%)
DateAnnualQuarterly
Mar 2018
-
$25.34 M(+34.3%)
Dec 2017
$18.87 M(-27.1%)
$18.87 M(-20.2%)
Sep 2017
-
$23.66 M(-5.5%)
Jun 2017
-
$25.03 M(+1.1%)
Mar 2017
-
$24.75 M(-4.4%)
Dec 2016
$25.88 M(-37.6%)
$25.88 M(-7.0%)
Sep 2016
-
$27.84 M(-9.1%)
Jun 2016
-
$30.61 M(-14.1%)
Mar 2016
-
$35.65 M(-14.1%)
Dec 2015
$41.49 M(+58.0%)
$41.49 M(+3.4%)
Sep 2015
-
$40.11 M(-5.6%)
Jun 2015
-
$42.48 M(+79.9%)
Mar 2015
-
$23.61 M(-10.1%)
Dec 2014
$26.26 M(-41.3%)
$26.26 M(-12.2%)
Sep 2014
-
$29.90 M(-11.5%)
Jun 2014
-
$33.77 M(-16.7%)
Mar 2014
-
$40.53 M(-9.4%)
Dec 2013
$44.75 M(<-9900.0%)
$44.75 M(+26.2%)
Sep 2013
-
$35.46 M(<-9900.0%)
Jun 2013
-
-$17.60 K(+21.4%)
Mar 2013
-
-$14.50 K(+28.3%)
Dec 2012
-$11.30 K(-145.6%)
-$11.30 K(+76.6%)
Sep 2012
-
-$6400.00(+814.3%)
Jun 2012
-
-$700.00(-103.5%)
Mar 2012
-
$20.00 K
Dec 2011
$24.80 K
-

FAQ

  • What is Lipocine annual working capital?
  • What is the all time high annual working capital for Lipocine?
  • What is Lipocine annual working capital year-on-year change?
  • What is Lipocine quarterly working capital?
  • What is the all time high quarterly working capital for Lipocine?
  • What is Lipocine quarterly working capital year-on-year change?

What is Lipocine annual working capital?

The current annual working capital of LPCN is $20.23 M

What is the all time high annual working capital for Lipocine?

Lipocine all-time high annual working capital is $44.75 M

What is Lipocine annual working capital year-on-year change?

Over the past year, LPCN annual working capital has changed by -$12.23 M (-37.67%)

What is Lipocine quarterly working capital?

The current quarterly working capital of LPCN is $18.92 M

What is the all time high quarterly working capital for Lipocine?

Lipocine all-time high quarterly working capital is $44.75 M

What is Lipocine quarterly working capital year-on-year change?

Over the past year, LPCN quarterly working capital has changed by -$1.31 M (-6.46%)